SHC
NASDAQSotera Health Company
News · 26 weeks60+800%
2026-03-012026-08-23
Mix2490d
- Insider15(63%)
- SEC Filings4(17%)
- Other2(8%)
- Earnings2(8%)
- Analyst1(4%)
Latest news
25 items- INSIDERExecutive Chairman Petras Michael B. Jr. sold $21,174,786 worth of shares (1,144,515 units at $18.50), decreasing direct ownership by 43% to 397,912 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Sotera Health CompanySCHEDULE 13G/A - Sotera Health Co (0001822479) (Subject)
- SECSotera Health Company filed SEC Form 8-K: Leadership Update8-K - Sotera Health Co (0001822479) (Filer)
- INSIDERPresident of Sterigenics Rutz Michael P sold $2,825,250 worth of shares (150,000 units at $18.84), decreasing direct ownership by 31% to 334,279 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERSr. Vice President, CFO Lyons Jonathan M. covered exercise/tax liability with 11,316 shares, decreasing direct ownership by 5% to 217,304 units (SEC Form 4) (tax liability)4 - Sotera Health Co (0001822479) (Issuer)
- SECSEC Form 144 filed by Sotera Health Company144 - Sotera Health Co (0001822479) (Subject)
- SECSEC Form 10-Q filed by Sotera Health Company10-Q - Sotera Health Co (0001822479) (Filer)
- SECSotera Health Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Sotera Health Co (0001822479) (Filer)
- PRSotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 OutlookQ2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis(1) compared to Q2 2025Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025Q2 2026 Adjusted EBITDA(1) increased 10.0%, or 8.7% on a constant currency basisQ2 2026 Adjusted EPS(1) of $0.26, an increase of 30% per diluted shareCompany raises both full-year 2026 net revenues growth outlook to 5.25% - 6.75% and Adjusted EBITDA growth outlook to 5.75% - 7.25%, on a constant currency basis CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (NASDAQ:SHC), a leading global provider of mission-c
- PRSotera Health Announces Second-Quarter 2026 Earnings Release DateCLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s operating and financial results. A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company’s website at Presentation & Ev
- ANALYSTGoldman initiated coverage on Sotera Health with a new price targetGoldman initiated coverage of Sotera Health with a rating of Buy and set a new price target of $20.00
- SECSEC Form SD filed by Sotera Health CompanySD - Sotera Health Co (0001822479) (Filer)
- INSIDERDirector Klee Ann R. was granted 14,970 shares, increasing direct ownership by 12% to 140,926 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERChief Executive Officer Shader Alton was granted 579,573 shares (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERSEC Form 3 filed by new insider Shader Alton3 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Kyle Richard G was granted 14,970 shares (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Krause Kenneth D. was granted 14,970 shares (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Cunningham Sean Laurence was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Flynn Karen was granted 14,970 shares, increasing direct ownership by 38% to 54,191 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Neary James was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Petrella Vincent K was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Chen Ruoxi was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Simon, Christopher was granted 14,970 shares, increasing direct ownership by 78% to 34,102 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- INSIDERDirector Wheadon David E. was granted 14,970 shares, increasing direct ownership by 20% to 89,882 units (SEC Form 4)4 - Sotera Health Co (0001822479) (Issuer)
- SECSotera Health Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Sotera Health Co (0001822479) (Filer)
SHC FAQ
7 questionsWhat does Sotera Health Company do?
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly...Where does SHC stock trade?
Sotera Health Company (SHC) is listed on NASDAQ.What sector and industry is SHC in?
Sotera Health Company operates in the Health Care sector, Misc Health and Biotechnology Services industry.When did Sotera Health Company go public?
Sotera Health Company (SHC) completed its IPO in 2020.What are analysts saying about SHC?
Sotera Health Company has had 8 recent analyst actions on file. The most recent action was from Goldman: Buy with a $2000.00 price target on 2026-06-05. Recent price targets range from $1300.00 to $2400.00.What companies are similar to SHC?
Notable peers in the same industry include FMS (Fresenius Medical Care AG), DVA (DaVita Inc.), PGNY (Progyny Inc.), AGL (agilon health inc.), VMD (Viemed Healthcare Inc.). Compare SHC side-by-side with any of them on Quantisnow.How can I track SHC on Quantisnow?
Quantisnow aggregates Sotera Health Company's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SHC to receive live email and push alerts on every new disclosure.